Composition

Each ml contains 100mg Moxifloxacin Hydrochloride

Description

Moxifloxacin is a synthetic fluoroquinolone antibiotic agent. It is an antibiotic used to treat a number of bacterial infections. This includes pneumonia, conjunctivitis, endocarditis, tuberculosis, and sinusitis. It is used by mouth, by injection into a vein, or as an eye drop.

Chemical structure

Indications

Active against ocular pathogens like staphylococcus species and pseudomonas aerugenosis

Bacterial infection of eye

Bacterial conjunctivitis

Corneal ulceration

Skin infection

Pneumonia

Pharmacodynamics


Moxifloxacin is a quinolone/fluoroquinolone antibiotic. Moxifloxacin can be used to treat infections caused by the following bacteria: Aerobic Gram-positive microorganisms: Corynebacterium species, Micrococcus luteusStaphylococcus aureusStaphylococcus epidermidisStaphylococcus haemolyticusStaphylococcus hominisStaphylococcus warneriStreptococcus pneumoniae, and Streptococcus viridans group. Aerobic Gram-negative microorganisms: Haemophilus influenzae, and Haemophilus parainfluenzae. Other microorganisms: Chlamydia trachomatis.
Moxifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Moxifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria

Mechanism of action

The bactericidal action of moxifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division.

Toxicity

Symptoms of overdose include CNS and gastrointestinal effects such as decreased activity, somnolence, tremor, convulsions, vomiting, and diarrhea. The minimal lethal intravenous dose in mice and rats is 100 mg/kg.

Contraindications

Contraindicated in animals below 6 month of age

Presentation

25 ml

Leave a Comment

Rudrapur Plant
Village- Lalpur, Kichha- Rudrapur Road, Rudrapur, U.S. Nagar, Uttarakhand, India - 263148

Agra Plant
B36, EPIP, Industrial Area, Sikandra, Agra, Uttar Pradesh, India - 282007

Safecon Lifesciences © 2021. All rights reserved.